Genetic Technologies
GENE
$2.28
Share price
-6.56%
Change (1 day)
105.41%
Change (1 year)
Categories
Operating Margin for Genetic Technologies (GENE)
Operating Margin as of April 2024 (TTM): -105.42%
According to Genetic Technologies's latest financial reports and stock price the company's current Operating Margin is -105.42%. At the end of 2022 the company had an Operating Margin of -105.42%.
Operating Margin history for Genetic Technologies from 2004 to 2008
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -105.42% | -98.2% |
| 2021 | -5,870.91% | -90.5% |
| 2020 | -61,830.19% | 144.83% |
| 2019 | -25,253.91% | 774.73% |
| 2018 | -2,887.06% | 78.13% |
| 2017 | -1,620.78% | 57.99% |
| 2016 | -1,025.84% | 134.26% |
| 2015 | -437.90% | 97.22% |
| 2014 | -222.04% | -19.8% |
| 2013 | -276.84% | 92.92% |
| 2012 | -143.50% | -3009.59% |
| 2011 | 4.93% | -105.14% |
| 2010 | -95.88% | 12.2% |
| 2009 | -85.46% | 146.14% |
| 2008 | -34.72% | 232.78% |
| 2007 | -10.43% | -80.57% |
| 2006 | -53.71% | -29.66% |
| 2005 | -76.35% | -57.62% |
| 2004 | -180.17% | 285.9% |
| 2003 | -46.69% | -31.15% |
| 2002 | -67.82% | 10.93% |
| 2001 | -61.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -113.44% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 11.10% | -110.53% | 🇺🇸 USA |
 Danaher DHR | 26.34% | -124.99% | 🇺🇸 USA |
 LabCorp LH | 10.63% | -110.08% | 🇺🇸 USA |
 Compugen CGEN | -89.54% | -15.06% | 🇮🇱 Israel |
 Neogen NEOG | -2.68% | -97.46% | 🇺🇸 USA |
 Myriad Genetics MYGN | -20.72% | -80.35% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.